FDAnews
www.fdanews.com/articles/100839-canceled-vaccine-may-have-boosted-hiv-risk

Canceled Vaccine May Have Boosted HIV Risk

November 8, 2007

New evidence suggests that Merck & Co.’s experimental HIV vaccine may have made its recipients more vulnerable to the deadly AIDS virus — and has prompted researchers to warn participants in other trials that similarly made vaccines for a range of other diseases might also increase their susceptibility to HIV.
The Wall Street Journal